Distinctive binding properties of human monoclonal LGI1 autoantibodies determine pathogenic mechanisms

Abstract excerpt

Autoantibodies against leucine-rich glioma inactivated 1 (LGI1) are found in patients with limbic encephalitis and focal seizures. Here, we generate patient-derived monoclonal antibodies (mAbs) against LGI1. We explore their sequences and binding characteristics, plus their pathogenic potential using transfected HEK293T cells, rodent neuronal preparations, and behavioural and electrophysiological assessments in...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Autoimmune Neurological Disorders and Treatments
• Share to Cellular transport and secretion
• Share to Peripheral Neuropathies and Disorders